Lanxess, DE0005470405

Lanxess stock gains as Q3 cash flow turns positive

Published on 11/06/2026 at 18:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Lanxess stock gains support from stronger third-quarter sales and earnings. Management sees full-year EBITDA before exceptional items near the top of its revised range.

Key points for investors

  • LANXESS increased third-quarter sales and adjusted earnings despite a weak economic environment.
  • Specialty Additives led earnings growth, while other segments remained exposed to energy costs and cyclical demand.
  • Management expects positive fourth-quarter free cash flow and EBITDA before exceptional items near the upper end of its revised range.
Lanxess, DE0005470405, Illustration mit AI erstellt.

LANXESS reported stronger third-quarter sales and earnings on Thursday, November 5, 2026, while narrowing its full-year outlook. In its third-quarter release, the specialty chemicals group said sales rose 9.6 percent year over year to EUR 1.467 billion, while EBITDA before exceptional items increased 11.2 percent to EUR 139 million.

Lanxess stock traded at 13.12 euros on Lang & Schwarz at 18:09 CET on Friday, November 6, 2026, 0.15 percent above the Xetra close of 13.10 euros on Friday, November 6. Compared with the 12.99-euro quote in the previous report published on Thursday, November 5, the stock was 1.001 percent higher.

Cash flow improves alongside guidance

Free cash flow turned positive at EUR 48 million in the third quarter, compared with a negative EUR 14 million a year earlier. LANXESS also expects positive free cash flow in the fourth quarter, keeping cash generation a central focus for the final reporting period.

Management now expects full-year EBITDA before exceptional items near the upper end of a EUR 450 million to EUR 500 million range. The revised range is narrower than the previously cited EUR 450 million to EUR 550 million range, giving investors a tighter benchmark for fourth-quarter execution.

Segment performance remains uneven

Specialty Additives was the strongest earnings contributor. Its EBITDA before exceptional items rose 57.8 percent to EUR 71 million, supported by pricing and cost reductions. Consumer Protection lifted sales to EUR 491 million, but EBITDA declined 6.9 percent to EUR 67 million.

Advanced Intermediates increased sales 7.2 percent to EUR 404 million, while EBITDA before exceptional items slipped to EUR 25 million from EUR 26 million. LANXESS cited high energy costs, weak construction and agricultural demand, and low Rhine water levels as continuing operating pressures.

Investors will focus on whether pricing, savings and segment momentum can offset seasonal weakness and support the upper end of the revised earnings range. The real-time quote of Lanxess stock remains a short-term market indicator rather than a substitute for the company’s fourth-quarter operating performance.

The DAX provides the relevant market context for German equities; investors can follow its latest market developments.

Further company-specific developments are available in more news and analyses on Lanxess stock.

Lanxess AG stock facts

  • Company: Lanxess AG
  • ISIN: DE0005470405
  • Ticker: LXS.DE
  • Lang & Schwarz quote: 13.12 euros on November 6, 2026 at 18:09 CET
  • Change versus previous report: 1.001 percent above the 12.99-euro quote from November 5, 2026 at 17:46 CET
  • Change versus Xetra close: 0.15 percent above the Xetra close
  • Xetra close: 13.10 euros on November 6, 2026
Disclaimer...
en | DE0005470405 | LANXESS | boerse | 70471436 |